Public misperceptions of COVID-19 vaccine effectiveness and waning: experimental evidence from Ireland.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 05 09 2022
revised: 27 10 2022
accepted: 01 11 2022
pubmed: 16 12 2022
medline: 13 1 2023
entrez: 15 12 2022
Statut: ppublish

Résumé

The study set out to measure public understanding of COVID-19 vaccine effectiveness (VE) and how effectiveness wanes with time since vaccination. Because perceived VE is a strong predictor of vaccine uptake, measuring perceptions can inform public health policy and communications. Online randomised experiment. The study was undertaken in Ireland, which has high vaccination rates. A nationally representative sample (n = 2000) responded to a scenario designed to measure perceptions of COVID-19 VE against mortality. The length of time since vaccination in the scenario was randomly varied across four treatment arms (2 weeks, 3 months, 6 months, and 9 months). The public underestimates VE, with substantial variation in perceptions. A majority (57%) gave responses implying perceived VE against mortality of 0-85%, i.e., below scientific estimates. Among this group, mean perceived VE was just 49%. Over a quarter (26%) gave responses implying perceived VE greater than 95%, i.e., above scientific estimates. Comparing the four treatment groups, responses took no account of vaccine waning. Perceived VE was actually higher 9 months after vaccination than 2 weeks after vaccination. Despite high vaccination rates, most of the public in Ireland underestimates VE. Furthermore, the general public has not absorbed the concept of vaccine waning in the months following vaccination. Both misperceptions may reduce vaccine uptake, unless public health authorities act to correct them through improved communication.

Identifiants

pubmed: 36521276
pii: S0033-3506(22)00318-3
doi: 10.1016/j.puhe.2022.11.002
pmc: PMC9650565
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-84

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

BMC Infect Dis. 2022 May 7;22(1):439
pubmed: 35525973
N Engl J Med. 2021 Dec 2;385(23):2195-2197
pubmed: 34670038
BMJ. 2022 Jul 20;378:e071249
pubmed: 35858698
BMJ. 2011 Oct 17;343:d6386
pubmed: 22006953
Lancet. 2022 Feb 26;399(10327):814-823
pubmed: 35131043
Vaccine. 2022 Oct 6;40(42):6035-6041
pubmed: 36088194
BMJ Open. 2022 Aug 3;12(8):e063935
pubmed: 35922100
Br J Health Psychol. 2022 May;27(2):300-319
pubmed: 34250684
Psychol Med. 2021 Aug 31;:1-4
pubmed: 34462018
Hum Vaccin Immunother. 2021 Sep 2;17(9):2940-2945
pubmed: 33998949
Front Public Health. 2021 Aug 13;9:698111
pubmed: 34485229
N Engl J Med. 2022 Mar 10;386(10):933-941
pubmed: 35020982
Front Immunol. 2021 Jun 14;12:558270
pubmed: 34194418

Auteurs

P D Lunn (PD)

Economic and Social Research Institute & Department of Economics, Trinity College Dublin, Ireland, ESRI, Whitaker Square, Sir John Rogerson's Quay, Dublin 2, Ireland. Electronic address: pete.lunn@esri.ie.

S Timmons (S)

Economic and Social Research Institute & Department of Psychology, Trinity College Dublin, Ireland. Electronic address: shane.timmons@esri.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH